Tiziano Pramparo
About Tiziano Pramparo
Tiziano Pramparo serves as the Director of Genetic Epidemiology at Travere Therapeutics, where he has worked since 2021. He has extensive experience in biomedical research, having held various positions at notable institutions and contributed significantly to the field through publications and patents.
Current Role at Travere Therapeutics
Tiziano Pramparo serves as the Director of Genetic Epidemiology at Travere Therapeutics, a position he has held since 2021. In this role, he focuses on advancing the understanding of genetic factors in disease and their implications for therapeutic development. His work contributes to the company's mission of delivering innovative treatments for patients with rare diseases.
Previous Experience in Genetic Research
Prior to his current role, Tiziano Pramparo held various positions in genetic research and consulting. He worked as a Senior Biomarker Scientist at Epic Sciences from 2019 to 2020 and as a Research Specialist at the University of California, San Francisco from 2007 to 2011. His experience includes consulting roles at MD Revolution and Accel Diagnostics, LLC, where he contributed to research and product development.
Educational Background and Qualifications
Tiziano Pramparo has an extensive educational background in genetics and related fields. He earned his Doctor of Philosophy (PhD) in Human Genetics from Baylor College of Medicine and the University of Pavia, Italy, completing his studies in 2004. He also holds a Bachelor's degree in Biological Sciences from the University of Pavia and has pursued further studies in Biostatistics and Data Science.
Research Contributions and Publications
Tiziano Pramparo has made significant contributions to the field of biomedical research, with over 50 peer-reviewed articles and 5 book chapters published. He has been awarded 8 research grants and holds 2 patents related to biomedical research. His h-index of 21 reflects his impact on the scientific community and his commitment to advancing knowledge in genetic epidemiology.
Innovations in Genetic Technologies
Throughout his career, Tiziano Pramparo has focused on the development and optimization of high-throughput technologies for molecular and genomic applications. He has implemented new platforms to enhance the identification and translation of therapeutic targets, particularly for central nervous system disorders and cancer, demonstrating his dedication to advancing medical research.